Article
A Multi-Center Retrospective Study Evaluating Palliative Antineoplastic Therapy Administered and Medication De-escalation in Veteran Cancer Patients Toward the End-of-life
- Author:
- Megan Banaszynski, PharmD, Bcop
- Thao Truong, PharmD
- Holly Embree, PharmD, BCPS, BCGP
- Grace Cullen, DNP, FNP-BC, ACHPN, RN-BC
- Mency Zhu, PharmD
- Jenna Houranieh, PharmD, BCOP
- Brian J. Dahl, PharmD, Bcop
- Jenny L. New, PharmD
- Brent A. Harris, PharmD, MBA
- Brooke Sorgen Crawford, PharmD, BCOP
Publish date: September 1, 2020
Article
The Cost of Oncology Drugs: A Pharmacy Perspective, Part 2
- Author:
- Brian J. Dahl, PharmD, Bcop
Guidance documents, the Pharmacy Benefits Management Services, and the VA National Formulary help clinicians and pharmacists decide whether to...
News
The Cost of Oncology Drugs: A Pharmacy Perspective, Part I
- Author:
- Brian J. Dahl, PharmD, Bcop
Even in the VA, the high cost of oncology medications are forcing health care providers to confront the economic impact of cancer care.